|
Arterial thrombosis
Citations 91-100 of 112 total displayed.
|
Past content
(since Mar 2001):
|
- Articles
Protein Z Deficiency in Antiphospholipid-Negative Sneddon’s Syndrome
- Nakhlé Ayoub, Gaetan Esposito, Stéphane Barete, Claudine Soria, Jean-Charles Piette, and Camille Francès
Stroke published April 22, 2004, doi:10.1161/01.STR.0000127534.54538.15
[Abstract]
- Original Contributions
Risk of Ischemic Stroke Associated With Functional Thrombin-Activatable Fibrinolysis Inhibitor Plasma Levels
- A. Santamaría, A. Oliver, M. Borrell, J. Mateo, R. Belvis, J. Martí-Fábregas, R. Ortín;, I. Tirado, J.C. Souto, and J. Fontcuberta
Stroke 2003;34:2387-2391; published online before print as doi:10.1161/01.STR.0000088642.07691.15
[Abstract]
[Full text]
- Articles
Risk of Ischemic Stroke Associated With Functional Thrombin-Activatable Fibrinolysis Inhibitor Plasma Levels
- A. Santamaría, A. Oliver, M. Borrell, J. Mateo, R. Belvis, J. Martí-Fábregas, R. Ortín, I. Tirado, J. C. Souto, and J. Fontcuberta
Stroke published August 28, 2003, doi:10.1161/01.STR.0000088642.07691.15
[Abstract]
- Original Contributions
Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke
- Randall T. Higashida and Anthony J. Furlan
Stroke 2003;34:e109-137e; published online before print as doi:10.1161/01.STR.0000082721.62796.09
[Abstract]
[Full text]
- Articles
Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke
- Randall T. Higashida and Anthony J. Furlan
Stroke published July 17, 2003, doi:10.1161/01.STR.0000082721.62796.09
[Abstract]
- Original Contributions
Is Thrombogenesis in Atrial Fibrillation Related to Matrix Metalloproteinase-1 and Its Inhibitor, TIMP-1?
- Francisco Marín, Vanessa Roldán, Vicente Climent, Amaya García, Pascual Marco, and Gregory Y.H. Lip
Stroke 2003;34:1181-1186; published online before print as doi:10.1161/01.STR.0000065431.76788.D9
[Abstract]
[Full text]
- Original Contributions
Comparison of Triflusal and Aspirin for Prevention of Vascular Events in Patients After Cerebral Infarction: The TACIP Study: A Randomized, Double-Blind, Multicenter Trial • Can Aspirin Ever Be Surpassed for Stroke Prevention?
- Jordi Matías-Guiu, José M. Ferro, José Alvarez-Sabín, Ferran Torres, M. Dolores Jiménez, Aida Lago, Teresa Melo, and David C. Tong
Stroke 2003;34:840-848; published online before print as doi:10.1161/01.STR.0000063141.24491.50
[Abstract]
[Full text]
- Research Reports
Thrombin-Activable Fibrinolysis Inhibitor Levels in the Acute Phase of Ischemic Stroke
- Joan Montaner, Marc Ribó, Jasone Monasterio, Carlos A. Molina, and José Alvarez-Sabín
Stroke 2003;34:1038-1040; published online before print as doi:10.1161/01.STR.0000063139.06585.45
[Abstract]
[Full text]
- Articles
Is Thrombogenesis in Atrial Fibrillation Related to Matrix Metalloproteinase-1 and Its Inhibitor, TIMP-1?
- Francisco Marín, Vanessa Roldán, Vicente Climent, Amaya García, Pascual Marco, and Gregory Y.H. Lip
Stroke published March 27, 2003, doi:10.1161/01.STR.0000065431.76788.D9
[Abstract]
- Articles
Comparison of Triflusal and Aspirin for Prevention of Vascular Events in Patients After Cerebral Infarction. The TACIP Study: A Randomized, Double-Blind, Multicenter Trial
- Jordi Matías-Guiu, José M. Ferro, José Alvarez-Sabín, Ferran Torres, M. Dolores Jiménez, Aida Lago, and Teresa Melo
Stroke published March 20, 2003, doi:10.1161/01.STR.0000063141.24491.50
[Abstract]
|
|
